Abstract
Heat is one of the oldest forms of therapy used to treat cancers. Numerous references to cauterization for local tumor destruction are made in the ancient literature. Hippocrates states in Aphorism LXXXVII: ‘Those diseases that medicines do not cure are cured by the knife. Those that the knife does not cure are cured by fire. Those that fire does not cure, must be considered incurable’ [1]. In the late 19th century several reports were made regarding the spontaneous regression of malignant tumors in patients who experienced a fever [2–4]. The first such report was made by Busch in 1866. Around the turn of the 20th century, researchers discovered that malignant tumors are more sensitive to heat-induced damage than normal tissues [5,6]. Since then, numerous clinical experiments have used heat alone, or in combination with surgery, radiation, or chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jones S, Henry W. Hippocrates. Cambridge, MA: Harvard University Press, 1962.
Busch W. Uber den Einflus Weichen Heftigere Erysipelen Zuweilen auf Organisierte Neubildungen Ausuken Verhandl, Rheinisch-Westfael. Akad Wiss Nat Lng Wirtschaftswiss Vortr 1866;23:28.
Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases. Am J Med Sci 1893;105:487.
Vidal E. Cancer et traumatism. In Alcan F, ed. Paris: Assoc Franc de Chirurgie, 1907.
Jensen CO. Experimentelle Untersuchunger Uber Krebs bei Mausen. Zentralbl Parasitenkd Infektionskr 1903;34:28.
Loeb L. Transplantation von Tumoren. Virchows Arch Pathol Anat Physiol 1903; 172:345.
Hornback NB. Historical aspects of hyperthermia in cancer therapy. Radiol Clini North Am 1989;27:481.
Los G, van Vugt MJH, den Engelse, Pinedo HM. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA. Biochem Pharmacol 1993;46:1229–1237.
Los G, van Vugt MJH, Pinedo HM. Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994;69:235–241.
Los G, Sminia P, Wondergem J, et al. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 1991;27:472–477.
Perry M, ed The Chemotherapy Source Book. Baltimore, MD: Williams & Wilkins, 1993.
Shimm DS, Gerner EW. Hyperthermia in the treatment of malignancies. In Lehmann J, ed. Therapeutic Heat and Cold. Baltimore, MD: Williams & Wilkins, 1990.
Oesterreich S, Weng CN, Qiu M, et al. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 1993;53:4443–4448.
Nakata B, Barton R, Howell SB, Los G. Association between over-expression of hsp60 and cisplatin resistance in head and neck cancer cells. Proc Am Assoc Cancer Res 1994;35:466.
Rabindran SK, Brown EB, Greenberger LM. Heat shock proteins are associated with mitoxantrone resistance in human colon carcinoma cells. Proc Am Assoc Cancer Res 1994;35:466.
Lucassen MA, van Eden W. Immune recognition of heat shock protein-60 (HSP60). Sigma ImmuNotes 1994;12:1–3.
Barlogie B, Corry PM, Drewinko B. In-vitro Thermochemotherapy of human colon cancer cells with cis-dichloroammineplatinum (II) and mitomycin C. Cancer Res 1987;40:1165–1168.
Meyn RE, Corry PM, Fletcher SE, et al. Thermal enhancement of DNA damage in mammalian cells treated with cis-diaminedichloro-platinum (II). Cancer Res 1980;83:312–322.
Wallner KE, Li GC. Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin C and cisplatin. Cancer Res 1987;47:493–495.
Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, et al. Rationale for integrating postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83–97.
Casper ES, Kelsen SP, Alcock NW, Lewis JL. Intraperitoneal cisplatin in patients with malignant ascites: Pharmacokinetic evaluation and comparison with the intravenous route. Cancer Treat Rep 1983;7:235.
Markman M, Cleary S, Lucas WE, Howell SB. Intraperitoneal chemotherapy with high dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies primarily involving the peritoneal cavity. J Clin Oncol 1985;3:925–931.
Ozols R. Intraperitoneal chemotherapy in management of ovarian cancer. Semin Oncol 1985; 12:75.
Bulger RE, Dobyan DC. Proliferative lesions found in the rat after a single dose of cisplatinum. J Natl Cancer Inst 1984;73:1235.
Chopra S, Kaufman JS, Jones TW, Hong WU, et al. Cis-diamminedichloroplatinum induced acute renal failure in the rat. Kidney Int 1982;21:54.
Los G, Mutsaers PHA, Lenglet WJM, Baldew GS, McVie JG. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Pharmacol 1990;00:389–394.
Gilly FN, Carry PY, Brachet A, et al. Treatment of malignant peritoneal effusion in digestive and ovarian cancer. Med Oncol Tumor Pharmacother 1992;9:177–81.
Gilly FN, Carry PY, Sayag AC, et al. Cancers of the stomach and peritoneal carcinoses: Will hyperthermia be a new therapeutic approach? Ann Chir 1993;47:414–418.
Fujimoto S, Shrestha RD, Kokubun M, et al. Clinical outcome of combined therapy of intraoperative hyperthermochemotherapy and surgery for patients with peritoneal recurrence from gastric cancer. Reg Cancer Treat 1990;3:181–184.
Fujimoto S, Shrestha RD, Kokubun M, et al. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990;212:592–596.
Fujimoto S, Makoto T, Endoh F, et al. A clinical pilot study combining surgery with intraoperative pelvic hyperthermochemotherapy to prevent local recurrence of rectal cancer. Ann Surg 1991;213:43–47.
Fujimura T, Yonemura Y, Fushida S, et al. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65–71.
Kitamura K, Kuwano H, Matsuda H, To HY, Masuda H, Sugimachi K. Synergistic effects of intratumor administration of cis-diamminedichloroplatinum (II) combined with local hyperthermia in melanoma bearing mice. J Surg Oncol 1992;51:188–194.
Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44:605–612.
Jain RK. Bioheat transfer: Mathematical models of thermal systems. In Hyperthermia in Cancer Therapy. Boston, MA: G.K. Hall Medical, 1983, pp. 9–46.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Stephens, A.D., Belliveau, J.F., Sugarbaker, P.H. (1996). Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Drugs and Diseases. Cancer Treatment and Research, vol 81. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1245-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1245-1_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-3726-3
Online ISBN: 978-1-4613-1245-1
eBook Packages: Springer Book Archive